five

Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison

收藏
DataCite Commons2020-08-28 更新2024-07-27 收录
下载链接:
https://scielo.figshare.com/articles/Botulinum_toxin_A_BT-A_versus_low-level_laser_therapy_LLLT_in_chronic_migraine_treatment_a_comparison/7336694/1
下载链接
链接失效反馈
官方服务:
资源简介:
ABSTRACT The aim of this work was to evaluate patients with chronic migraine treated with botulinum toxin A (BT-A) and compare this with low level laser therapy (LLLT), referencing: pain days, pain intensity, intake of drugs/self-medication, anxiety and sleep disorders. Methods: Patients were randomized into two groups: BT-A group (n = 18) and LLLT group (n = 18). Each patient kept three pain diaries: one before (baseline) (30 days), one during treatment (30 days) and one after the post-treatment phase (30 days). Repeated ANOVA plus the Bonferroni post-test, Student's t test, and factorial analysis were applied, and p < 0.05 was accepted as significant. Results: Our data showed that both treatments were able to reduce headache days, acute medication intake and decrease the intensity of pain. Anxiety was reduced in the BT-A group, while sleep disturbance was reduced in the LLLT group. Conclusion: Our data showed that both treatments can be used to treat chronic migraine, without notable differences between them.
提供机构:
SciELO journals
创建时间:
2018-11-14
二维码
社区交流群
二维码
科研交流群
商业服务